HIGH

Cardinal Health Recalls Sulfamethoxazole and Trimethoprim Over Microbial Risk

Cardinal Health recalled Sulfamethoxazole and Trimethoprim tablets on September 2, 2025, due to contamination risks. A specific lot contained a foreign substance with a detected micro-organism, although no contamination was found on the tablets. Consumers must stop using the product immediately and seek guidance from healthcare providers.

Quick Facts at a Glance

Recall Date
September 2, 2025
Hazard Level
HIGH
Brands
SULFAMETHOXAZOLE AND TRIMETHOPRIM, Cardinal Health 107, Major Pharmaceuticals
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

Presence of a Foreign Substance: A specific lot of auxiliary polyester coil, used in product packaging by manufacturer (Amneal Pharmaceuticals LLC) was detected with presence of a micro-organism. No micro-organism was detected on any tablets.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories or your healthcare provider for guidance. Notification method: Letter

Product Details

The recalled product is Sulfamethoxazole and Trimethoprim, USP, 800 mg/160 mg, Double Strength, in unit dose blister packs. It is distributed by Cardinal Health, Dublin, OH, and identified under NDC 55154-7895-0. The affected inner blister lot is N02309, with an expiration date of March 31, 2027.

The Hazard

The recall stems from the presence of a micro-organism detected in an auxiliary polyester coil used in the product's packaging. This poses a potential health risk, classified as Class II by the FDA.

Reported Incidents

There are no reported incidents of contamination on the tablets themselves, and no injuries have been documented related to this recall.

What to Do

Stop using the product immediately. Consumers should contact The Harvard Drug Group, LLC, or their healthcare provider for further guidance. A notification letter will be sent to affected parties.

Contact Information

For more information, consumers can reach The Harvard Drug Group, LLC at their website or by phone. Details about the recall are also available on the FDA's website.

Key Facts

  • Recalled product: Sulfamethoxazole and Trimethoprim, USP, 800 mg/160 mg
  • Distributed by Cardinal Health
  • Affected lot: N02309, Exp. 03/31/2027
  • No contamination found on tablets
  • Stop using the product immediately

Safety Assessment

Risk LevelHIGH
Severity Score
7/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product TypeSulfamethoxazole and Trimethoprim Tablets
Sold At
Multiple Retailers

Product Details

Model Numbers
Bag: N02309A and N02309B
Inner blister: Lot # N02309
UPC Codes
55154-7895
0904-2725
55154-7895-0
+1 more
Affected States
ALL
Report Date
September 17, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

HIGH

Acuity Specialty Products Recalls Hand Sanitizer Due to Methanol Risk

Acuity Specialty Products recalled its Wyandotte Sanifect E3 hand sanitizer on September 29, 2025. The recall affects multiple package configurations due to potential methanol contamination. Consumers should stop using the product immediately and contact the company for guidance.

Acuity Specialty Products
cGMP deviations:
Read more
HIGH

AFCO Hand Sanitizer Recalled Due to Methanol Risk

AFCO recalled hand sanitizer on September 29, 2025, due to a risk of methanol contamination. The company failed to conduct required testing on incoming alcohol components. Consumers should stop using the product immediately.

AFCO
cGMP deviations:
Read more